1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > MediPoint: Coronary Stents - Current and Future Players

MediPoint: Coronary Stents - Current and Future Players

  • November 2014
  • -
  • Global Data
  • -
  • 234 pages

MediPoint: Coronary Stents - Current and Future Players

Summary

The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.

The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation.

Scope

- Investigation of current and future market competition for Coronary Stents.
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Coronary Stents market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table Of Contents

MediPoint: Coronary Stents - Current and Future Players
1 Table of Contents

2 Introduction 12
2.1 Catalyst 13
2.2 Related Reports 14
3 Competitive Assessment 15
3.1 Overview 15
3.2 Trends in Coronary Stent Technology Development 16
3.2.1 Development of Bare Metal Stents 16
3.2.2 Development of Drug-Eluting Stents 18
3.2.3 Development of Bioabsorbable Stents 21
3.2.4 Development of Covered Stents 22
3.2.5 Coronary Stent Technology SWOT Analysis 23
4 Pipeline Products 24
4.1 Overview 24
4.2 Pipeline by Stage of Development 24
4.3 Pipeline Product Profiles 27
4.3.1 Bioabsorbable Stents 27
4.3.2 Other Types of Vascular Stents 38
5 Current and Future Players 44
5.1 Overview 44
5.2 Trends in Corporate Strategy 44
5.3 Company Profiles 47
5.3.1 Abbott Vascular 47
5.3.2 Boston Scientific Corporation 53
5.3.3 Medtronic 59
5.3.4 Alvimedica 65
5.3.5 Amaranth Medical 69
5.3.6 amg International 72
5.3.7 Arterial Remodeling Technologies 76
5.3.8 B. Braun 79
5.3.9 Balton 82
5.3.10 Biosensors International 87
5.3.11 Biotronik 91
5.3.12 Blue Medical 96
5.3.13 Cardionovum 100
5.3.14 C.R. Bard 104
5.3.15 Elixir Medical Corporation 108
5.3.16 eucatech AG 113
5.3.17 Hexacath 117
5.3.18 IRAMED 120
5.3.19 JW Medical Systems 123
5.3.20 Kyoto Medical Planning 126
5.3.21 Lepu Medical Technology 129
5.3.22 MicroPort Scientific Corporation 133
5.3.23 Minvasys 137
5.3.24 MIV Therapeutics 141
5.3.25 Opto Circuits 145
5.3.26 OrbusNeich Medical 149
5.3.27 Relisys Medical Devices 153
5.3.28 REVA Medical 157
5.3.29 Sahajanand Medical Technologies 160
5.3.30 STENTYS 164
5.3.31 Terumo Corporation 168
5.3.32 Translumina 172
5.3.33 Vascular Concepts 175
5.3.34 Other Companies 179
6 Appendix 191
6.1 Bibliography 191
6.2 Abbreviations 215
6.3 Report Methodology 222
6.3.1 Overview 222
6.3.2 Coverage 222
6.3.3 Secondary Research 222
6.4 Physicians and Specialists Included in This Study 224
6.4.1 Praveen Chandra, MD, DM, FESC, FSCAI, FAPSCI 224
6.4.2 Bernado Cortese, MD, FESC 224
6.4.3 Ricardo A. Costa, MD 224
6.4.4 Thomas Cuisset, MD, PhD, FESC 224
6.4.5 Nobuyuki Komiyama, MD, PhD, FACC, FJCC 224
6.4.6 Roger J. Laham, MD 224
6.4.7 Mark W. Mewissen, MD 224
6.4.8 Gary S. Mintz, MD 224
6.4.9 Tudor C. Poerner, MD 225
6.4.10 David Ramsdale, MD, PhD 225
6.4.11 Gregory A. Sgueglia, MD, PhD 225
6.4.12 Madhukar Shahi, MD 225
6.4.13 Takehiro Yamashita, MD, PhD, FACC 225
6.5 Primary Research 226
6.5.1 Primary Research - Key Opinion Leader Interviews 226
6.5.2 Primary Research Interviews- Physician and Industry Participants 226
6.5.3 Physican Survey 227
6.5.4 Expert Panel Validation 228
6.6 Forecasting Methodology 229
6.7 About the Authors 231
6.7.1 Analysts 231
6.7.2 Global Head of Healthcare 232
6.8 About MediPoint 233
6.9 About GlobalData 233
6.10 Disclaimer 233

1.1 List of Tables

Table 1: Coronary Stent Technology SWOT Analysis, 2014 23
Table 2: Global Coronary Stent Pipeline Products, 2014 26
Table 3: ART18Z SWOT Analysis, 2014 28
Table 4: DREAMS SWOT Analysis, 2014 29
Table 5: Fantom SWOT Analysis, 2014 30
Table 6: Fortitude SWOT Analysis, 2014 31
Table 7: Ideal BioStent SWOT Analysis, 2014 32
Table 8: Igaki-Tamai Stent SWOT Analysis, 2014 34
Table 9: ON-AVS SWOT Analysis, 2014 35
Table 10: Other Companies Developing BAS, 2014 38
Table 11: FOCUS np Eluting Stent SWOT Analysis, 2014 39
Table 12: STENTYS Sirolimus-Eluting Stent SWOT Analysis, 2014 40
Table 13: Svelte Drug-Eluting Stent SWOT Analysis, 2014 42
Table 14: Abbott Vascular Company Profile 47
Table 15: Abbott Vascular Coronary Stent Marketed Products 49
Table 16: Abbott Vascular Coronary Stent Product Portfolio SWOT Analysis, 2014 52
Table 17: Abbott Vascular SWOT Analysis, 2014 53
Table 18: Boston Scientific Corporation Company Profile 54
Table 19: Boston Scientific Coronary Stent Marketed Products 56
Table 20: Boston Scientific Coronary Stent Product Portfolio SWOT Analysis, 2014 58
Table 21: Boston Scientific Corporation SWOT Analysis, 2014 59
Table 22: Medtronic Company Profile 60
Table 23: Medtronic Coronary Stent Marketed Products 62
Table 24: Medtronic Coronary Stent Product Portfolio SWOT Analysis, 2014 64
Table 25: Medtronic SWOT Analysis, 2014 65
Table 26: Alvimedica Company Profile 66
Table 27: Alvimedica Coronary Stent Marketed Products 67
Table 28: Alvimedica Coronary Stent Product Portfolio SWOT Analysis, 2014 68
Table 29: Alvimedica SWOT Analysis, 2014 69
Table 30: Amaranth Medical Company Profile 70
Table 31: Amaranth Medical Coronary Stent Pipeline Product 70
Table 32: Amaranth Medical Coronary Stent Product Portfolio SWOT Analysis, 2014 71
Table 33: Amaranth Medical SWOT Analysis, 2014 71
Table 34: amg International Company Profile 72
Table 35: amg International Coronary Stent Marketed Products 74
Table 36: amg International Coronary Stent Product Portfolio SWOT Analysis, 2014 75
Table 37: amg International SWOT Analysis, 2014 76
Table 38: Arterial Remodeling Technologies Company Profile 77
Table 39: Arterial Remodeling Technologies Coronary Stent Pipeline Product 77
Table 40: Arterial Remodeling Technologies Coronary Stent Product Portfolio SWOT Analysis, 2014 78
Table 41: Arterial Remodeling Technologies SWOT Analysis, 2014 78
Table 42: B. Braun Company Profile 79
Table 43: B. Braun Coronary Stent Marketed Products 80
Table 44: B. Braun Coronary Stent Product Portfolio SWOT Analysis, 2014 81
Table 45: B. Braun SWOT Analysis, 2014 82
Table 46: Balton Company Profile 83
Table 47: Balton Coronary Stent Marketed Products 84
Table 48: BALTON Coronary Stent Product Portfolio SWOT Analysis, 2014 86
Table 49: Balton SWOT Analysis, 2014 86
Table 50: Biosensors International Company Profile 87
Table 51: Biosensors International Coronary Stent Marketed Products 89
Table 52: Biosensors International Coronary Stent Product Portfolio SWOT Analysis, 2014 90
Table 53: Biosensors International SWOT Analysis, 2014 91
Table 54: Biotronik Company Profile 92
Table 55: Biotronik Coronary Stent Marketed and Pipeline Products 93
Table 56: Biotronik Coronary Stent Product Portfolio SWOT Analysis, 2014 95
Table 57: Biotronik SWOT Analysis, 2014 96
Table 58: Blue Medical Company Profile 97
Table 59: Blue Medical Coronary Stent Marketed Products 98
Table 60: Blue Medical Coronary Stent Product Portfolio SWOT Analysis, 2014 99
Table 61: Blue Medical SWOT Analysis, 2014 100
Table 62: Cardionovum Company Profile 101
Table 63: Cardionovum Coronary Stent Marketed and Pipeline Products 102
Table 64: Cardionovum Coronary Stent Product Portfolio SWOT Analysis, 2014 103
Table 65: Cardionovum SWOT Analysis, 2014 104
Table 66: C.R. Bard Company Profile 105
Table 67: ClearStream Technologies Coronary Stent Marketed Products 106
Table 68: C.R. Bard Coronary Stent Product Portfolio SWOT Analysis, 2014 107
Table 69: C.R. Bard SWOT Analysis, 2014 108
Table 70: Elixir Medical Corporation Company Profile 109
Table 71: Elixir Medical Corporation Coronary Stent Marketed Products 110
Table 72: Elixir Medical Corporation Coronary Stent Product Portfolio SWOT Analysis, 2014 112
Table 73: Elixir Medical Corporation SWOT Analysis, 2014 113
Table 74: eucatech Profile 114
Table 75: eucatech Coronary Stent Marketed Products 115
Table 76: eucatech Coronary Stent Product Portfolio SWOT Analysis, 2014 116
Table 77: eucatech SWOT Analysis, 2014 117
Table 78: Hexacath Company Profile 118
Table 79: Hexacath Coronary Stent Marketed Products 119
Table 80: Hexacath Coronary Stent Product Portfolio SWOT Analysis, 2014 119
Table 81: Hexacath SWOT Analysis, 2014 120
Table 82: IRAMED Company Profile 120
Table 83: IRAMED Coronary Stent Marketed Products 121
Table 84: IRAMED Coronary Stent Product Portfolio SWOT Analysis, 2014 122
Table 85: IRAMED SWOT Analysis, 2014 123
Table 86: JW Medical Systems Company Profile 124
Table 87: JW Medical Systems Coronary Stent Marketed Product 124
Table 88: JW Medical Systems' Coronary Stent Product Portfolio SWOT Analysis, 2014 125
Table 89: JW Medical Systems SWOT Analysis, 2014 126
Table 90: Kyoto Medical Planning Company Profile 127
Table 91: Kyoto Medical Planning Coronary Stent Pipeline Product 128
Table 92: Kyoto Medical Planning Coronary Stent Product Portfolio SWOT Analysis, 2014 128
Table 93: Kyoto Medical Planning SWOT Analysis, 2014 129
Table 94: Lepu Medical Technology Company Profile 130
Table 95: Lepu Medical Technology Coronary Stent Marketed and Pipeline Products 131
Table 96: Lepu Medical Technology Coronary Stent Product Portfolio SWOT Analysis, 2014 132
Table 97: Lepu Medical Technology SWOT Analysis, 2014 133
Table 98: MicroPort Scientific Corporation Company Profile 134
Table 99: MicroPort Scientific Corporation Coronary Stent Marketed Products 135
Table 100: MicroPort Scientific Corporation Coronary Stent Product Portfolio SWOT Analysis, 2014 136
Table 101: MicroPort Scientific Corporation SWOT Analysis, 2014 137
Table 102: Minvasys Company Profile 138
Table 103: Minvasys Coronary Stent Marketed and Pipeline Products 139
Table 104: Minvasys Coronary Stent Product Portfolio SWOT Analysis, 2014 140
Table 105: Minvasys SWOT Analysis, 2014 141
Table 106: MIV Therapeutics Company Profile 142
Table 107: MIV Therapeutics Coronary Stent Marketed Products 143
Table 108: MIV Therapeutics Coronary Stent Product Portfolio SWOT Analysis, 2014 144
Table 109: MIV Therapeutics SWOT Analysis, 2014 145
Table 110: Opto Circuits Company Profile 146
Table 111: Opto Circuits Coronary Stent Marketed Products 147
Table 112: Opto Circuits Coronary Stent Product Portfolio SWOT Analysis, 2014 148
Table 113: Opto Circuits SWOT Analysis, 2014 149
Table 114: OrbusNeich Medical Company Profile 150
Table 115: OrbusNeich Medical Coronary Stent Marketed and Pipeline Products 151
Table 116: OrbusNeich Medical Coronary Stent Product Portfolio SWOT Analysis, 2014 152
Table 117: OrbusNeich Medical SWOT Analysis, 2014 153
Table 118: Relisys Medical Devices Company Profile 154
Table 119: Relisys Medical Devices Coronary Stent Marketed Products 155
Table 120: Relisys Medical Devices Coronary Stent Product Portfolio SWOT Analysis, 2014 156
Table 121: Relisys Medical Devices SWOT Analysis, 2014 157
Table 122: REVA Medical Company Profile 158
Table 123: REVA Medical Coronary Stent Pipeline Product 158
Table 124: REVA Medical Coronary Stent Product Portfolio SWOT Analysis, 2014 159
Table 125: REVA Medical SWOT Analysis, 2014 160
Table 126: Sahajanand Medical Technologies Company Profile 161
Table 127: Sahajanand Medical Technologies Coronary Stent Marketed and Pipeline Products 162
Table 128: Sahajanand Medical Technologies Coronary Stent Product Portfolio SWOT Analysis, 2014 163
Table 129: Sahajanand Medical Technologies SWOT Analysis, 2014 164
Table 130: STENTYS Company Profile 165
Table 131: STENTYS Coronary Stent Marketed and Pipeline Products 166
Table 132: STENTYS Coronary Stent Product Portfolio SWOT Analysis, 2014 167
Table 133: STENTYS SWOT Analysis, 2014 168
Table 134: Terumo Corporation Company Profile 169
Table 135: Terumo Corporation Coronary Stent Marketed and Pipeline Products 170
Table 136: Terumo Corporation Coronary Stent Product Portfolio SWOT Analysis, 2014 171
Table 137: Terumo Corporation SWOT Analysis, 2014 171
Table 138: Translumina Company Profile 172
Table 139: Translumina Coronary Stent Marketed Products 173
Table 140: Translumina Coronary Stent Product Portfolio SWOT Analysis, 2014 174
Table 141: Translumina SWOT Analysis, 2014 174
Table 142: Vascular Concepts Company Profile 175
Table 143: Vascular Concepts Coronary Stent Marketed Products 176
Table 144: Vascular Concepts Coronary Stent Product Portfolio SWOT Analysis, 2014 177
Table 145: Vascular Concepts SWOT Analysis, 2014 178
Table 146: Other Companies in the Coronary Stent Market, North America, 2014 179
Table 147: Other Companies in the Coronary Stent Market, EU, 2014 184
Table 148: Other Companies in the Coronary Stent Market, APAC, 2014 187
Table 149: Other Companies in the Coronary Stent Market, South Africa and South America, 2014 190
Table 150: Primary Research Interviews Completed 227
Table 151: Physicians Surveyed, By Country 228

1.2 List of Figures

Figure 1: Global Coronary Stents Market Value Share (%), 2013 and 2020 16
Figure 2: Global Coronary Stent Pipeline Products by Stage of Development, 2014 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Vascular Access Devices Market: Scope and Methodology Vascular access devices are medical devices used to obtain access to the bloodstream, and are hollow and flexible tubes made of latex, silicone, and ...

Czech Republic Interventional Cardiology Market Outlook to 2022

Czech Republic Interventional Cardiology Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Interventional Cardiology Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Interventional Cardiology Market Outlook to 2022, provides key market data on the Czech ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.